Impairment of the antioxidant properties of serum albumin in patients with diabetes: Protective effects of metformin

Clinical Science

Volumn 114, Issue 3-4, 2008, Pages 251-256

  Faure, Patrice ^a   Wiernsperger, Nicolas ^b   Polge, Camille ^c   Favier, Alain ^d   Halimi, Serge ^c  

^a University Grenoble Alpes   (France)

^b INSERM   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d CEA GRENOBLE   (France)

Author keywords

Albumin; Antioxidant; Glycation; Metformin; Sulfonylurea; Type 2 diabetes

Indexed keywords

ACRYLAMIDE; FRUCTOSAMINE; METFORMIN; SERUM ALBUMIN; SULFONYLUREA; THIOL GROUP; ANTIDIABETIC AGENT; ANTIOXIDANT; INSULIN; SULFONYLUREA DERIVATIVE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLUORESCENCE; GLYCATION; HUMAN; MALE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; OXIDATIVE STRESS; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; PROTECTION; PROTEIN CONFORMATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; AGED; BLOOD; CHEMISTRY; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

AGED; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; FLUORESCENCE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; OXIDATIVE STRESS; SERUM ALBUMIN; SULFONYLUREA COMPOUNDS;

EID: 38949158548     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070276     Document Type: Article

References (26)

1. Nathan, D. M., Buse, J. B., Davidson, M. B. et al. (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49, 1711-1721
2. Bonnefont-Rousselot, D., Raji, B., Walrand, S. et al. (2003) An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. Metab. Clin. Exp. 54, 586-589
3. Faure, P., Rossini, E., Wiernsperger, N., Richard, M. J., Favier, A. and Halimi, S. (1999) An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats. Diabetes 48, 353-357
4. Mahrouf, M., Ouslimani, N., Peynet, J. et al. (2006) Metformin reduces angiotensin-mediated intracellular production of reactive oxygen species in endothelial cells through the inhibition of protein kinase C. Biochem. Pharmacol. 72, 176-183
5. Gargiulo, P., Caccese, D., Pignatelli, P. et al. (2002) Metformin decreases platelet superoxide anion production in diabetic patients. Diabetes Metab. Res. Rev. 18, 156-159
6. Besswenger, P. and Ruggiero-Lopez, D. (2003) Metformin inhibition of glycation processes. Diabetes Metab. 29, 6S95-6S103
7. Schram, M. T., Schalkwijk, C. G. and Bootsma, A. H. (2005) Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. Hypertension 46, 232-237
8. Soriani, M., Pietraforte, D. and Minetti, M. (1994) Antioxidant potential of anaerobic human plasma: role of serum albumin and thiols as scavengers of carbon radicals. Arch. Biochem. Biophys. 312, 180-188
9. Diabetic Control and Complication Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977-986
10. Faure, P., Troncy, L., Lecomte, M. et al. (2005) Albumin antioxidant capacity is modified by methylglyoxal. Diabetes Metab. 31, 169-177
11. Kawakami, A., Kubota, K., Yamada, N. et al. (2006) Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions. FEBS J. 273, 3346-3357
12. Quinlan, G. J., Martin, G. S. and Evans, T. W. (2005) Albumin: biochemical properties and therapeutic potential. Hepatology 41, 1211-1219
13. Bourdon, E., Loreau, N. and Blache, D. (1999) Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J. 13, 233-244
14. Faure, P., Lafond, J. L., Coudray, C. et al. (1994) Zinc prevents the structural and functional properties of free radical treated-insulin. Biochim. Biophys. Acta 1209, 260-264
15. Jocelyn, P. C. (1987) Spectrophotometric assay of thiols. Methods Enzymol. 143, 44-67
16. Gunzler, W. A., Kremers, H. and Flohe, L. (1974) An improved coupled test for glutathione peroxidase in blood. Z. Klin. Chem. Klin. Biochem. 12, 444-448
17. Grotto, D., Santa Maria, L. D. et al. (2007) Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection. J. Pharm. Biomed. Anal. 43, 619-624
18. Wang, B., Pan, J., Wang, L., Zhu, H., Yu, R. and Zou, D. (2006) Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease. Atherosclerosis 184, 425-430
19. Phillips, A., Shaper, A. G. and Whincup, P. H. (1989) Association between serum albumin and mortality from cardiovascular diseases, cancer and other causes. Lancet ii, 1434-1436
20. Bourdon, E., Loreau, N., Lagrost, L. and Blache, D. (2005) Differential effects of cysteine and methionine residues in the antioxidant activity of human serum albumin. Free Radical Res. 39, 15-20
21. Shaklai, N., Garlik, R. L. and Bunn, H. F. (1984) Non enzymatic glycosylation of human serum albumin alters its conformation and function. J. Biol. Chem. 259, 3812-3817
22. Lee, H., Cha, M. K. and Kim, I. H. (2000) Activation of thiol-dependant antioxidant activity of human serum albumin by alkaline pH is due to the B-like conformational change. Arch. Biochem. Biophys. 380, 309-318
23. Cohen, M. P., Clements, R. S., Cohen, J. A. and Shearman, C. W (1996) Glycated albumin promotes a generalized vasculopathy in the db/db mouse. Biochem. Biophys. Res. Commun. 218, 72-75
24. Schalkwijk, C. G., Ligtvoet, N., Twaalfhoven, H. et al. (1999) Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes 48, 2446-2453
25. Hattori, Y., Suzuki, M., Hattori, S. and Kasai, K. (2002) Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hypertension 39, 22-28
26. Abbasi, F., Chu, J. W., McLaughlin, T., Lamendola, C., Leary, E. T. and Reaven, G. M. (2004) Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus. Metab. Clin. Exp. 53 159-164